Suppr超能文献

含炔基部分的氨基胍的合成、抗菌和抗癌活性及对接研究。

Synthesis, antibacterial and anticancer activity, and docking study of aminoguanidines containing an alkynyl moiety.

机构信息

Basic Medical and Pharmacy College, Jinggangshan University, Ji'an, China.

出版信息

J Enzyme Inhib Med Chem. 2020 Dec;35(1):354-364. doi: 10.1080/14756366.2019.1702654.

Abstract

Two series of aminoguanidines containing an alkynyl moiety were designed, synthesised, and screened for antibacterial and anticancer activities. Generally, the series with a 1,2-diphenylethyne exhibited better antibacterial activity than the other series () holding 1,4-diphenylbuta-1,3-diyne moiety antibacterial activity. Most compounds in series showed potent growth inhibition against the tested bacterial strains, with minimum inhibitory concentration (MIC) values in the range 0.25-8 µg/mL. Compound demonstrated rapid and persistent bactericidal activity at 2 × MIC. The resistance study revealed that resistance of the tested bacteria towards is not easily developed. Molecular docking studies revealed that compounds and bind strongly to the LpxC and FabH enzymes. Moreover, excellent activity of selected compounds against the growth of cancer cell lines A549 and SGC7901 was also observed, with IC values in the range 0.30-4.57 µg/mL. These findings indicate that compounds containing the aminoguanidine moiety are promising candidates for the development of new antibacterial and anticancer agents.

摘要

设计、合成并筛选了两个含有炔基部分的氨基胍系列化合物,用于抗菌和抗癌活性研究。通常,具有 1,2-二苯乙炔部分的系列化合物的抗菌活性优于具有 1,4-二苯基丁-1,3-二炔部分的其他系列化合物。系列化合物中大多数化合物对测试的细菌菌株表现出很强的生长抑制作用,最小抑菌浓度(MIC)值在 0.25-8μg/mL 范围内。化合物在 2×MIC 时表现出快速和持久的杀菌活性。耐药性研究表明,测试细菌对化合物的耐药性不易产生。分子对接研究表明,化合物和结合到 LpxC 和 FabH 酶上的能力很强。此外,还观察到选定化合物对肺癌细胞系 A549 和 SGC7901 的生长具有优异的活性,IC 值在 0.30-4.57μg/mL 范围内。这些发现表明,含有氨基胍部分的化合物是开发新型抗菌和抗癌药物的有前途的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f18/6968633/10d9a92711e8/IENZ_A_1702654_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验